Unit-6: Animal Cell Culture Technology

1. Introduction to Animal Cell Culture

Animal cell culture is the process of growing animal cells in vitro under controlled artificial conditions. The culture environment supplies essential nutrients, growth factors, and appropriate physiological parameters such as temperature, pH, and gas mixture.

Definition: Animal cell culture refers to the removal of cells from an animal organ or tissue and their subsequent growth in a favorable artificial environment.

1.1 Primary Culture and Subculturing

Primary culture is the initial phase of culture starting from fresh cells isolated directly from animal tissues by mechanical disaggregation or enzymatic digestion (using trypsin or collagenase).

• Primary Explant Culture: Small tissue pieces are attached to a substrate, and cells migrate outward.
• Enzymatic Dissociation: Enzymes break extracellular matrix bonds to release individual cells.
• Subculture (Passaging): Transferring cells from an established culture vessel to a fresh culture vessel containing fresh medium to allow continued proliferation.

1.2 Finite vs. Continuous Cell Lines

Cell lines generated from primary cultures generally have a limited life span or can become immortalized.

Exam Note: Remember that primary cells undergo senescence due to telomere shortening, whereas continuous cell lines overcome this via telomerase activation or genomic transformations.

Common Mistake: Confusing primary culture with a cell line. Primary culture lasts until the first subculturing step; once passaged, the culture becomes a cell line.

2. Animal Cell Culture Technology and Media

Culture media provide the nutritional, hormonal, and buffering environment required for animal cell survival and proliferation.

2.1 Physico-Chemical Conditions

• pH: Typically maintained between 7.2 and 7.4.
• Temperature: Kept at 37°C for mammalian cells.
• Carbon Dioxide (CO2): Maintained at 5%–10% in air to buffer bicarbonate systems.
• Osmolality: Kept within 260–320 mOsm/kg.
• Relative Humidity: Maintained above 95% to prevent media evaporation.

2.2 Types of Media

Culture media are divided into natural and synthetic media.

2.3 Key Media Components

• Carbon & Energy Source: Glucose, glutamine.
• Amino Acids: Essential amino acids (cannot be synthesized by cells) and non-essential amino acids.
• Vitamins: B-group vitamins act as metabolic cofactors.
• Inorganic Salts: Na+, K+, Ca2+, Mg2+, Cl-, and phosphate ions to balance osmolality and cell signaling.
• Buffering System: Sodium bicarbonate combined with gaseous CO2, or organic buffers like HEPES.
• pH Indicator: Phenol red (turns yellow at acidic pH, pink/purple at alkaline pH).

2.4 Role of Serum in Culture Media

Fetal Bovine Serum (FBS) is commonly added (5%–10% v/v) to provide essential growth factors.

Important Concept: Functions of Serum:

1. Provides essential hormones and growth factors (e.g., insulin, PDGF).
2. Promotes cell attachment and spreading via matrix factors (fibronectin, vitronectin).
3. Protects cells from shear force stress in liquid media.
4. Acts as a buffer and detoxifying agent by binding heavy metals.

Disadvantages of Serum: Batch-to-batch variation, risk of viral/mycoplasma contamination, high cost, and downstream purification interference.

3. Characterization of Cell Lines

Characterization ensures authenticity, identifies inter- or intra-species contamination, and verifies cell lineage consistency.

3.1 Parameters for Cell Characterization

1. Morphology: Visual observation using phase-contrast microscopy (e.g., epithelial, fibroblastic, or lymphoblastoid morphology).
2. Karyotyping: Chromosome analysis to determine species origin, chromosome number, and structural abnormalities.
3. DNA Fingerprinting / STR Analysis: Short Tandem Repeat profiling to authenticate individual human cell lines and rule out cross-contamination.
4. Isoenzyme Analysis: Electrophoretic verification of specific enzyme patterns (e.g., G6PD) to confirm species identity.
5. Cell Surface Markers: Immunological detection of specific antigens using monoclonal antibodies or flow cytometry (FACS).

3.2 Growth Kinetic Parameters

Evaluating growth kinetics helps assess population doubling times and culture health.

Formulas:
Population Doubling Time: PDT = (t * log 2) / (log N - log N0)
Specific Growth Rate: μ = (ln N - ln N0) / t
Where t is time interval, N0 is initial cell density, and N is final cell density.

3.3 Contamination Testing

• Bacterial and Fungal: Identified through visual turbidity, microscopic checks, or agar culture plates.
• Mycoplasma: Wall-less bacteria detected via PCR, DAPI fluorescent staining, or specialized broth culture.
• Viral Contamination: Assayed through ELISA, PCR, or cytopathic effect (CPE) screening.

4. Scale-Up of Animal Cell Culture Process

Scale-up expands cell culture operations from bench scale to commercial biomanufacturing volumes while retaining target yields and cellular functionality.

4.1 Scale-Up Systems Comparison

4.2 Bioreactors for Animal Cell Culture

• Stirred-Tank Bioreactors: Uses marine impellers operating at low agitation speeds to minimize hydrodynamic shear force.
• Airlift Bioreactors: Circulation driven by gas bubbling, offering reduced shear stress compared to mechanical impellers.
• Microcarrier Systems: Small solid or porous beads (100–200 µm) suspended in liquid, allowing anchorage-dependent cells to scale up in suspension culture vessels.
• Hollow-Fiber Bioreactors: Cells grow at high density in the extra-capillary space while media flows inside semi-permeable hollow fibers.

4.3 Major Challenges in Industrial Scale-Up

• Shear Sensitivity: Animal cells lack a rigid cell wall, making them susceptible to mechanical damage from impellers and gas bubble bursting.
• Oxygen Transfer: Bubble sparging supplies oxygen but creates surface tension shear; requires careful sparging or bubble-free aeration tubing.
• Toxic Metabolite Accumulation: Accumulation of lactate and ammonium ions inhibits growth and alters product glycosylation patterns.

5. Applications of Animal Cell Culture

Animal cell culture is widely utilized across biopharmaceuticals, medical research, and toxicology.

5.1 Major Industrial and Biomedical Applications

1. Monoclonal Antibody (mAb) Production: Generated via hybridoma technology (fusion of B-lymphocytes with immortal myeloma cells) to yield targeted therapeutic antibodies (e.g., Rituximab, Trastuzumab).
2. Viral Vaccine Production: Cultivation of viruses in cells (e.g., Vero cells, human diploid cells) for vaccines against polio, rabies, measles, hepatitis A, and influenza.
3. Recombinant Therapeutic Proteins: Expression of complex human proteins requiring post-translational modifications (e.g., Erythropoietin, Factor VIII, tissue Plasminogen Activator) predominantly in Chinese Hamster Ovary (CHO) cells.
4. Toxicity Testing and Drug Screening: In vitro cytotoxicity assays (e.g., MTT assay) reduce reliance on animal models during drug discovery.
5. Tissue Engineering: Combining cell cultures with 3D biocompatible scaffolds to create replacement tissues (e.g., artificial skin grafts, cartilage repair tissue).

6. Stem Cell Technology

Stem cells are undifferentiated cells capable of self-renewal and multi-lineage differentiation.

Definition: Stem cells are unspecialized biological cells that can differentiate into specialized cell types and divide through mitosis to produce more stem cells.

6.1 Potency Spectrum

• Totipotent: Can give rise to all cell types, including embryonic and extra-embryonic tissues (e.g., zygote and early cleavage stage blastomeres).
• Pluripotent: Can differentiate into cells derived from all three germ layers (ectoderm, mesoderm, endoderm) (e.g., Embryonic Stem Cells).
• Multipotent: Can develop into multiple cell lineages within a specific tissue family (e.g., Hematopoietic Stem Cells forming blood cell types).
• Unipotent: Can produce only one cell type, but retain self-renewal capacity (e.g., Spermatogonial stem cells).

6.2 Stem Cell Types

6.3 Key Applications and Ethical Aspects

• Regenerative Medicine: Repairing damaged tissues in conditions like Parkinson's disease, spinal cord injury, and diabetes.
• Disease Modeling: Patient-derived iPSCs help model genetic diseases in vitro.
• Ethical & Regulatory Considerations: Human ESC research involves destruction of blastocysts, requiring strict legal frameworks, oversight committees, and consent protocols worldwide.